Capricor Therapeutics | CAPR - Los Gastos Financieros De La Deuda





Los Gastos Financieros De La Deuda Cambio Fecha
Bioline Rx USD 280K 80K 2025-12
Capricor Therapeutics 3.05M 2.46M 2025-12
Cipla INR 170.3M 39M 2026-06
Cytokinetics USD 34.83M 1.5M 2026-06
Geron USD 7.15M 150K 2026-03
Grifols EUR 156.07M 31.46M 2025-09
Immunic 197K 222K 2025-12
J&J USD 43M 25M 2026-03
Plus Therapeutics USD 62K 25K 2023-12
Prothena USD 302.58M 47.32M 2026-06
PTC Therapeutics USD 3.25B 381.37M 2026-06
Sarepta Therapeutics USD 21.51M 205K 2026-06